JAK2 Antikörper (AA 916-1103)
Kurzübersicht für JAK2 Antikörper (AA 916-1103) (ABIN7620971)
Target
Alle JAK2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 916-1103
-
Verwendungszweck
- Janus Kinase 2 (JAK2) Polyclonal Antibody
-
Sequenz
- Val916~Thr1103
-
Produktmerkmale
- The Janus Kinase 2 (JAK2) Polyclonal Antibody (Species: Rat) has been validated for the following applications: WB, IHC, ICC, IP.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- JAK2 (Janus Kinase 2 (JAK2))
-
Andere Bezeichnung
- JAK2
-
Gen-ID
- 24514
-
UniProt
- Q62689
-
Pathways
- JAK-STAT Signalweg, RTK Signalweg, Interferon-gamma Pathway, Positive Regulation of Peptide Hormone Secretion, Intracellular Steroid Hormone Receptor Signaling Pathway, Response to Growth Hormone Stimulus, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Platelet-derived growth Factor Receptor Signaling, Unfolded Protein Response
Target
-